Skip to Content




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of Alzheimer's disease

Treatment of neurological disorders

Chemical Name

2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid (WHO)

Foreign Names

  • Tafamidisum (Latin)
  • Tafamidis (German)
  • Tafamidis (French)
  • Tafamidis (Spanish)

Generic Names

  • Tafamidis (OS: USAN, BAN)
  • Fx-1006 (IS)
  • UNII-8FG9H9D31J (IS)
  • Tafamidis Meglumine (OS: USAN, JAN, BANM)
  • Fx-1006A (IS)
  • UNII-ZU7CF08A1A (IS)

Brand Names

  • Vyndaqel
    Pfizer, Spain; Pfizer, Lithuania; Pfizer, Poland; Pfizer, Slovenia
  • Vyndaquel
    Pfizer, Croatia (Hrvatska)
  • Vyndaqel
    Pfizer, Austria; Pfizer, Belgium; Pfizer, Germany; Pfizer, Denmark; Pfizer, France; Pfizer, Greece; Pfizer, Hungary; Pfizer, Netherlands; Pfizer, Portugal; Pfizer, Romania; Pfizer, Sweden; Pfizer Italia, Italy
  • Vyndaqel Soft
    Pfizer, Greece


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.